I have heard this song many many times. That is more of a hope, not a certainty. Expansion of tests means MORE TIME TO COMPLETION. Test results still do not mean SALES. What a lot of shareholders do not realize is that this stock could trade from .50 to $3 for months to come, if not longer. The test expansion could also find ISSUES, you never know.
There was a poster here that supposedly works at Sheba and intimated that the results were around 78%. True or not, I don't know, but that's pretty good in the pharma industry.